Dr. Karam Diaby participates in National Human Genome Research Institute Strategic Planning Workshop

The National Human Genome Research Institute, NHGRI, invited Karam Diaby, Ph.D., an assistant professor of pharmaceutical outcomes and policy in the University of Florida College of Pharmacy, to participate in a panel discussion shaping the organization’s strategic plan. The strategic planning workshop was held in Bethesda, Maryland, and will help NHGRI establish a “2020 vision for genomics” and culminate in the publication of a new NHGRI strategic plan in October.

Karam DiabyDiaby was invited to the panel to provide a health economic perspective on genomic medicine. His research assesses the value of new health care intervention technology, including pharmacogenomics testing. Diaby serves as a co-investigator on an NIH grant where he offers analysis of the cost-effectiveness of genotype-guided approaches to pain and the selection of antidepressants. On another grant, he is assessing the cost-effectiveness of rapid whole genome sequencing compared to its omission in critically ill pediatric patients.